FlexStake Partners with CP Fiberglass; Enters African Market

Fort Myers-based FlexStake Inc., a world leader in the manufacture of high impact markers has announced its partnership with CP Fiberglass Ltd, a Lagos-Nigeria, based company with interest in high performance infrastructural solutions.

Entering the African market opens a new vista for FlexStake reach into international business with substantial benefits for many projects in Traffic management, Utility companies, Oil & Gas industry, Aviation and Civil works.

"This partnership is about two companies that place premium on high performance products and shared vision. A robust match that benefits infrastructure across the African continent in her drive for sustainable development," said Robert Hughes Jr., CEO FlexStake Inc.

With Africa's biggest market, Nigeria, an important US partner, is considered a strategic gateway to lucrative opportunities in Africa's emerging economies. According to Emma Adoghe, CEO of CP Fiberglass Ltd, "We are thrilled at the opportunity to partner with FlexStake Inc. because it fulfills an important piece of our vision of providing technologically advanced solutions that benefits our communities. Harsh operational environments in many African countries demand infrastructural components that can perform with fidelity for extended periods. The lack of access to materials and technical skills for needed maintenance aggravates this necessity," he said.

Barely hitting the shelf, high impact markers are already enhancing vehicular traffic for many projects including Carlton Gate Estate – a planned unit development in Lekki, Victoria Island – Lagos. Currently, CP Fiberglass Ltd is engaged in talks with some partners about its traffic decongestion project for Lagos – a mega-city with notorious traffic congestion.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.